2022
DOI: 10.1155/2022/2155018
|View full text |Cite
|
Sign up to set email alerts
|

miR-124-3p Combined with ANGPTL2 Has High Diagnostic Values for Obese and Nonobese Polycystic Ovary Syndrome

Abstract: Polycystic ovary syndrome (PCOS) is a hormonal disorder that affects 5–20% of women of reproductive age. Interestingly, serum miR-124-3p and ANGPTL2 are differentially expressed in PCOS patients. Accordingly, this study set out to explore the clinical roles of serum miR-124-3p/ANGPTL2 in PCOS. Firstly, miR-124-3p/ANGPTL2 expression patterns were detected in the serum of 102 PCOS patients and 100 healthy subjects. miR-124-3p or/and ANGPTL2 diagnostic efficacy on PCOS was further analyzed, in addition to the mea… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 60 publications
0
1
0
Order By: Relevance
“…miRNAs have been identified as excellent candidate noninvasive biomarkers because of their high stability and abundance in serum (30,31). Therefore, numerous studies have evaluated the diagnostic potential of various miRNAs, such as miR-320b, miR-125b, miR-221-3p, and miR-124-3p (32)(33)(34)(35). However, the diagnostic performance of a single circulating miRNA is limited.…”
Section: Discussionmentioning
confidence: 99%
“…miRNAs have been identified as excellent candidate noninvasive biomarkers because of their high stability and abundance in serum (30,31). Therefore, numerous studies have evaluated the diagnostic potential of various miRNAs, such as miR-320b, miR-125b, miR-221-3p, and miR-124-3p (32)(33)(34)(35). However, the diagnostic performance of a single circulating miRNA is limited.…”
Section: Discussionmentioning
confidence: 99%